Access
To read this story in full you will need to login or make a payment (see right).
Scientific Correspondence
Nature 394, 531-532 (6 August 1998) | doi:10.1038/28970
nature jobs
Senior Manager-Pharma / CRO-Strategic Sourcing
- Varda Biotech
- Mumbai India
Chemical Reaction Engineering & Reactor Design
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Triclosan targets lipid synthesis
Laura M. McMurry1, Margret Oethinger1 & Stuart B. Levy1
Abstract
Triclosan is a broad-spectrum antibacterial and antifungal agent1,2, which acts by previously undetermined mechanisms, that is used in products such as antiseptic soaps, toothpastes, fabrics and plastics. Here we show that triclosan blocks lipid synthesis in Escherichia coli, and that mutations in, or overexpression of, the gene fabI (which encodes enoyl reductase, involved in fatty acid synthesis) prevents this blockage. This is, to our knowledge, the first evidence that triclosan acts on a specific bacterial target, rather than as a nonspecific 'biocide'.
To read this story in full you will need to login or make a payment (see right).

